  Clinical and metabolic characteristics of the studied groups.                                                   Control (*n* = 0000)   Subclinical atherosclerosis (*n* = 000)   *P*   ---------------------------------------------- ---------------------- ----------------------------------------- ----------   Age (years)                                    00 ± 0                 00 ± 0                                    